MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular ...
Idaho Technology, Inc. announced the European launch of its FilmArray Respiratory Panel (FilmArray RP), a multiplex clinical diagnostic product that simultaneously detects 21 respiratory pathogens in ...
SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., announced today the FDA clearance of its FilmArray Blood Culture Identification (BCID) Panel. To date, the 27-target panel is the most ...
May 18, 2012 — The US Food and Drug Administration (FDA) has given 510(k) clearance to the FilmArray Respiratory Panel to include testing for Bordetella pertussis, Mycoplasma pneumoniae, and ...
Idaho Technology, Inc.,(ITI) a privately held clinical diagnostics company, has received the US Food and Drug Administration (FDA) 510(k) clearance of five additional pathogens for its FilmArray ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
The US Food and Drug Administration (FDA) today approved the first nucleic acid-based test of cerebrospinal fluid (CSF) that can simultaneously detect 14 pathogens responsible for central nervous ...
* Filmarray RP EZ will be available on the US market only, Biofire anticipates commercial launch in November 2016 Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results